Taysha Gene Therapies Inc (TSHA)
EBITDA Margin
-2714.33%
TTM · Period ending:
TSHA EBITDA Margin
Latest reported-2714.33%period ending
Latest reported-2714.33%period ending
TSHA EBITDA Margin (0.00% → -2714.33%)
Annual ebitda margin
High-resolution chart · PNG
TSHA ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -1,102.906% | |
| -1,055.4542% | |
| -680.8427% | |
| -6,436.6107% | |
| 0% | |
| 0% | |
| 0% |